An AI-integrated drug discovery platform that explores the untapped chemical space to find new therapeutic stars.
Our AI algorithm explores chemical space for target-specific molecules with better properties than existing drugs.
Underneath its core, our technology utilizes multi-parameter optimization to generate high-quality molecules satisfying the given parameters.
No matter what target, our AI technology enables efficient discovery of novel molecular structures in a matter of few days.
Our AI algorithms learn from chemical, biological and physical simulations and do not rely on datasets of compounds.
Being dataset-independent dramatically expands the pool of potential drug targets and allows to work with unconventional targets such as RNA structures.
Our AI platform opens novel avenues to rationally design more effective but less toxic compounds acting on multiple therapeutic targets at once.
Building up on the "one drug multiple targets" philosophy, our platform utilizes cutting-edge AI technology for generating polypharmacological compounds.
The flexibility of our technology allows to not only design compounds acting on multiple targets at once, but also to control specificity and off-target side-effects.